Patients must not have any co-existing condition that would preclude full compliance with the study; no prior history of severe hypersensitivity reaction to docetaxel or other drugs formulated with polysorbate 
Prior history of allergic reactions to docetaxel and/or to medications formulated with polysorbate 
History of allergic reactions or severe hypersensitivity reactions to drugs formulated with polysorbate  or antisense oligonucleotides
Prior therapy with cabazitaxel or to other drugs formulated with polysorbate 
Any history of severe hypersensitivity reaction to docetaxel or other drugs formulated with polysorbate 
Patients with a history of severe hypersensitivity reaction to docetaxel or other drugs formulated with polysorbate . Please refer to Study Appendix O for a complete list of Polysorbate  containing drugs.
Known hypersensitivity to docetaxel or other drugs formulated with polysorbate 
Patients with a history of severe hypersensitivity reaction to Taxotere (docetaxel) or other drugs formulated with polysorbate 
Participant has a known sensitivity to docetaxel or other drugs formulated with polysorbate 
Patients with a history of severe hypersensitivity reaction to Taxotere or other drugs formulated with polysorbate 
Patients must not have a history of a grade  anaphylactic reaction to monoclonal antibody therapy or known hypersensitivity reactions to drugs formulated with polysorbate 
History of severe hypersensitivity reaction to paclitaxel, docetaxel, or to other drugs formulated with polysorbate  or polyoxyethylated castor oil, or to vinflunine or other vinca alkaloids
History of allergic reactions to compounds of similar chemical composition to the study drugs (docetaxel, cisplatin, carboplatin, erlotinib or their excipients), or other drugs formulated with polysorbate 
Patients with a history of severe hypersensitivity reaction to JEVTANA (cabazitaxel) or other drugs formulated with polysorbate 
History of allergic reactions to compounds of similar chemical composition to the study drugs (docetaxel, cisplatin, carboplatin, erlotinib or their excipients), or other drugs formulated with polysorbate 
Patients with a history of severe hypersensitivity reaction to Taxotere or other drugs formulated with polysorbate 
The subject has a history of severe hypersensitivity reactions to drugs formulated with polysorbate ;
Part  only: Patients with a history of severe hypersensitivity reaction to drugs formulated with polysorbate  (for example, drugs formulated with polysorbate  include, but are not limited to: Aranesp, Eprex, Cordarone, some vaccines).
History of allergic reactions or severe hypersensitivity reactions to drugs formulated with polysorbate  or antisense oligonucleotides.
Has a known sensitivity to capecitabine, any of its components, or other drugs formulated with polysorbate 
History of severe hypersensitivity reaction to drugs formulated with polysorbate 
Patients with a history of severe hypersensitivity reaction to docetaxel or other drugs formulated with polysorbate  are excluded from participation
Patient has prior hypersensitivity reaction or intolerance to docetaxel or other drugs formulated with polysorbate 
